Future Market Insights has announced the addition of the “Orthobiologics Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
London, UK -- (SBWIRE) -- 09/10/2015 -- Biologic treatment has made a significant impact in orthopedic surgery, incorporating patient's own cells, tissues, proteins produced artificially, etc. in the orthopedic treatment. The demand for global orthobiologics market is increasing due to the rise in aging population, changing lifestyles, problems associated with musculoskeletal system and developments in technologies. The global orthobiologics market is anticipated to grow with double digit growth rate over the forecast period with the demand for modern, safer and effective orthopedic biologic treatment. The strong growth of global orthobiologics market is predominantly driven by increasing cases of arthritis and obesity. In global orthobiologics market, the procedure of bone graft is largest segment.
Orthobiologics Market: Drivers & Restraints
The increasing innovations in technologies, aging population, presence of large number of unidentified and chronic diseases, increase in life expectancy and government initiatives are some of the drivers for the growth of global orthobiologics market. The musculoskeletal related issues especially implants have increased the demand for global orthobiologics market. The laidback lifestyle of the people, increasing rates of obesity and urbanization are driving global orthobiologics market. The technological advancement in developing pharmaceutical alternatives, of making medical treatment more of preventive rather than curative and nations' policy for reducing the deficit in budget are some of the hindrance factors for the growth of global orthobiologics market.
Browse Full Report@ http://www.futuremarketinsights.com/reports/orthobiologics-market
Orthobiologics Market: Segmentation
On the basis of application, global orthobiologics market can be segmented into:
Joint replacement and reconstruction
On the basis of product, global orthobiologics market can be segmented into:
Bone Graft Substitutes
Demorelized Bone Matrix (DBM)
Bone Morphogenic Proteins (BMP)
Bone Growth Stimulators
Single Injection Viscosupplementation
Orthobiologics Market: Region-wise Outlook
Global orthobiologics market is foreseen to witness the highest growth in U.S.as the region is expected to have the highest growth rate of aging population, increase in life expectancy as well as rising incidences of geriatric-based diseases. Huge number of untapped patient population, medical tourism and economical cost are driving the growth of global orthobiologics market in the emerging nations such as India and China.
Orthobiologics Market: Key Players
Some of the key players for the global orthobiologics market are: Medtronic, Genzyme, DePuy, Stryker, Zimmer, Biomet, Smith & Nephew, Synthes, K2M and Wright medical technology, Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.
Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-786
The report covers exhaustive analysis on:
Supply & Demand
Competition & Companies involved
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Middle East and Africa (GCC, S. Africa, N. Africa)